Century Therapeutics IPO climbs to more than $242M; stock rises over 30%

The $242.65 million is the most raised in a local life sciences IPO since Passage Bio went public in March 2020.

Source: bizjournals.com Health Care:Pharmaceuticals headlines - June 23, 2021 Category: Pharmaceuticals Authors: John George Source Type: news